Ignite Creation Date:
2025-12-24 @ 9:54 PM
Ignite Modification Date:
2025-12-25 @ 7:33 PM
Study NCT ID:
NCT01004432
Status:
COMPLETED
Last Update Posted:
2015-04-30
First Post:
2009-10-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)
Sponsor:
Janssen Biotech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-12
Start Date Type:
None
Primary Completion Date:
2013-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-10
Completion Date Type:
ACTUAL
First Submit Date:
2009-10-29
First Submit QC Date:
None
Study First Post Date:
2009-10-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-03-13
Results First Submit QC Date:
None
Results First Post Date:
2014-05-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-04-09
Last Update Post Date:
2015-04-30
Last Update Post Date Type:
ESTIMATED